Chromium tends to enter the conversation at a vulnerable moment: a higher-than-expected glucose result, a family history of type 2 diabetes, stubborn weight changes or a social-media post promising fewer cravings. The appeal is easy to understand. If a mineral participates in insulin action and carbohydrate metabolism, perhaps adding more will fix the problem.

Human biology is rarely that linear. A nutrient can be essential without becoming more beneficial at progressively higher doses, and a biochemical role does not automatically predict a clinical result. The practical question is not whether chromium matters—it does—but whether chromium picolinate supplements meaningfully change blood glucose, body weight or health outcomes for the person considering them.

What is chromium picolinate?

Chromium is present in foods and supplements in the trivalent form, chromium(III). This should not be confused with hexavalent chromium, chromium(VI), an industrial contaminant with a very different safety profile. Chromium picolinate is chromium bound to picolinic acid, one of several supplemental forms.

The body appears to use chromium in processes related to insulin action and the metabolism of carbohydrate, fat and protein, although its exact mechanism remains unsettled. The U.S. National Institutes of Health also notes that there is no validated clinical test for chromium status and no clearly defined deficiency state in healthy people. That makes broad claims about being ‘chromium deficient’ difficult to verify outside unusual nutrition situations.

Biogénique’s reviewed label identifies 500 mcg of chromium from chromium picolinate in each capsule. The bottle contains 30 capsules, and the adult direction is one capsule once daily. Those product-specific facts should anchor any discussion; evidence for another form, amount or population is not automatically transferable.

What does NPN 80079694 support?

The reviewed Canadian label states that the product provides support for healthy glucose metabolism, helps the body metabolize carbohydrates and fats, and is a factor in the maintenance of good health. These are normal-function and nutrient-metabolism claims. They are not the same as saying the product treats diabetes, lowers an elevated A1C, prevents complications or replaces prescribed care.

Health Canada’s monograph framework includes chromium sources such as chromium(III) picolinate and permits carefully defined metabolism claims when the product meets the relevant conditions. The exact product label remains the controlling consumer instruction. Marketing copy should therefore stay close to the licensed wording and avoid stronger phrases such as ‘blood sugar regulation’ when readers could interpret them as treatment of abnormal glucose.

What does a 500 mcg dose mean?

A microgram is one-millionth of a gram. The adequate intake, or AI, for chromium is 35 mcg/day for adult men aged 19 to 50 and 25 mcg/day for adult women in that age group; the figures fall to 30 and 20 mcg after age 50. The AI is an estimate of intake that appears adequate—not a treatment dose, a minimum every person must supplement, or a ceiling.

Five hundred micrograms is therefore a supplemental amount well above the adult AI. That comparison does not by itself prove the dose is unsafe: no tolerable upper intake level has been established because the data are limited. It does show why ‘it is only a mineral’ is not a complete safety argument. A labelled high-dose supplement deserves the same medication and health-history review as other concentrated products.

Does chromium picolinate improve blood sugar?

The evidence is mixed. Some older trials in people with type 2 diabetes reported improvements in fasting glucose, insulin or A1C, including a 1997 study using 200 or 1,000 mcg/day. Later trials and reviews have not reproduced a dependable benefit across populations, doses and study designs.

A 2010 randomized trial in people at risk for type 2 diabetes found that chromium picolinate did not significantly improve insulin sensitivity, fasting glucose or A1C overall. The NIH evidence review concludes that average effects in diabetes studies are small, inconsistent and of uncertain clinical significance. For metabolic syndrome and people without diabetes, results are also largely negative or too limited for confident conclusions.

This is the difference between supporting normal metabolism and treating a disease. Someone with prediabetes or diabetes may have many reasons for changing glucose levels—food pattern, physical activity, sleep, stress, illness, medication adherence and the progression of the condition. A supplement should not be used to postpone testing, replace a prescribed medicine or justify less monitoring.

Does it help with weight loss or cravings?

Chromium is often marketed as a shortcut for appetite control, cravings or fat loss. Meta-analyses have found a small average difference in body weight—roughly three-quarters of a kilogram more than placebo in one NIH-summarized analysis—but the studies are heterogeneous, often short and judged to provide low-quality evidence. A small statistical difference is not automatically a noticeable or durable clinical benefit.

That result does not support calling chromium picolinate a fat burner, an appetite suppressant or a meaningful weight-management treatment. It also cannot tell an individual whether a change on the scale came from the supplement. Body weight is influenced by energy intake, activity, sleep, medication, fluid balance, health conditions and time. Marketing should not turn a modest group average into a personal promise.

Is picolinate proven to be better absorbed?

Picolinate is a defined chromium source, but naming a chemical form is not proof of superior clinical outcomes. Absorption studies and comparisons among chromium salts do not establish that a particular finished product works better for blood glucose or weight. ‘Bioavailable’ can describe the presence of an absorbable form; phrases such as ‘superior absorption,’ ‘more efficient than standard alternatives’ or ‘better results’ require direct, relevant substantiation.

The same rule applies to quality documentation. A certificate of analysis can show whether a lot met named specifications. It does not measure human absorption or clinical effectiveness unless it contains a validated test designed for that purpose—and routine finished-product COAs do not.

Who should ask a clinician or pharmacist first?

Chromium supplements deserve extra review when a medicine or health condition changes the risk-benefit balance. Bring the actual bottle, not just the ingredient name, because dose and formulation matter.

• People using insulin. Chromium could add to glucose-lowering effects and increase the risk of hypoglycemia.

• People taking metformin or other diabetes medicines. Additive effects may lower glucose more than expected, particularly when food intake or activity also changes.

• People taking levothyroxine. A small study found reduced levothyroxine absorption when taken at the same time as chromium picolinate; a pharmacist can advise on spacing and monitoring.

• People with kidney or liver disease. Safety information at higher supplemental intakes is limited, and isolated adverse-event reports warrant caution.

• People who are pregnant or breastfeeding, planning surgery, or managing multiple medicines and supplements. Individual review is more reliable than a generic interaction list.

Possible low blood sugar symptoms can include sweating, shaking, dizziness, hunger, confusion or weakness. Follow the treatment plan provided by your diabetes team and seek urgent help for severe symptoms, loss of consciousness or inability to swallow. Stop the supplement and seek advice for a suspected adverse reaction.

How should Biogénique Chromium Picolinate be taken?

The reviewed label directs adults to take one capsule once daily. Each capsule provides 500 mcg of chromium. Do not double a missed dose, combine several chromium products or increase the amount in pursuit of faster weight or glucose changes. Confirm the directions on the current bottle before use.

Timing may matter if you take levothyroxine or a glucose-lowering medicine. Because the appropriate plan depends on the specific medication and monitoring schedule, ask a pharmacist how to separate products rather than relying on a universal number of hours. Keep supplements out of reach of children.

What about chromium from food?

Chromium occurs in a range of foods, including meats, grain products, some vegetables, fruits, nuts and beverages. The amount varies with agricultural and manufacturing conditions, and food-composition estimates are imperfect. For most people, the useful foundation is still an overall eating pattern that supports cardiometabolic health rather than chasing a single nutrient number.

If the goal is better glucose management, consistent meals, fibre-rich foods, adequate protein, movement, sleep and prescribed care have a stronger practical role than treating chromium as a rescue ingredient. Supplementation may be a preference to discuss, but it should sit inside that larger plan.

What the available COA shows—and what it does not

The connected certificate reviewed for this draft is tied to lot 240617, manufactured in June 2024 and expired in May 2026. It records acceptable capsule weight variation and lock length, four-minute disintegration against a limit of 30 minutes, low measured microbial counts, negative named pathogens and results for arsenic, cadmium, lead and mercury against the listed specifications.

That is historical lot evidence only. It cannot be used to imply that inventory sold now has the same results, and the displayed test table does not provide a separate chromium assay result that substantiates a current potency percentage. It also does not prove absorption, blood-glucose improvement, weight loss, superiority or ‘every batch’ testing. Before publication, verify a current lot and restrict claims to the tests and results actually reported.

A practical decision framework

1. Name the goal. General nutrient support, a diagnosed glucose problem and weight loss are different questions with different evidence and care pathways.

2. Check the claim. NPN 80079694 supports healthy glucose metabolism and carbohydrate/fat metabolism; it does not authorize a diabetes-treatment or weight-loss promise.

3. Review medicines and conditions. Insulin, diabetes drugs, levothyroxine, kidney disease and liver disease change the conversation.

4. Use the product-specific dose. One 500 mcg capsule once daily; more is not proven better.

5. Define what success would mean. Avoid attributing normal day-to-day glucose or weight variation to the supplement without an agreed measurement plan.

6. Keep effective care in place. Do not replace prescribed medication, glucose monitoring, nutrition care or follow-up testing.

7. Reassess. If the intended benefit is absent or an adverse effect appears, stop and discuss the next step instead of escalating the dose.

Frequently asked questions

Can chromium picolinate lower A1C?

Some trials report small improvements, while others do not. The overall evidence is inconsistent and the clinical importance is uncertain. It should not replace diabetes treatment or monitoring.

Is chromium picolinate good for prediabetes?

A randomized trial in people at risk for type 2 diabetes found no significant overall improvement in insulin sensitivity, fasting glucose or A1C. Discuss proven risk-reduction steps with your clinician.

Will 500 mcg help me lose weight?

Research suggests at most a small average effect of little clinical significance, based on low-quality and varied studies. The product should not be presented as a fat burner or reliable weight-loss treatment.

Does it stop sugar cravings?

There is not strong, consistent human evidence that chromium picolinate reliably controls cravings. Hunger and cravings have many biological, behavioural and environmental influences.

Is 500 mcg too much?

It is well above the adult adequate intake, but the AI is not an upper limit and no chromium UL has been established. Limited safety data and individual conditions mean the labelled dose still deserves review.

Can I take it with metformin?

Chromium may add to the glucose-lowering effect of metformin or other diabetes medicines. Ask the clinician or pharmacist managing your therapy and follow their monitoring plan.

Can I take it with levothyroxine?

Taking chromium picolinate at the same time may reduce levothyroxine absorption. Ask a pharmacist for a product-specific spacing and monitoring plan.

Is chromium picolinate more absorbable than other forms?

The form is used in supplements, but that does not by itself prove superior absorption or better clinical outcomes for this finished product.

Does the NPN mean Health Canada proved it treats diabetes?

No. The NPN authorizes sale under specific labelled conditions and claims. This product’s reviewed claim concerns support for healthy metabolism, not treatment of diabetes.

How long should I take it?

The reviewed label provides a daily dose but no universal treatment course for glucose or weight outcomes. Set a review point with a clinician if you are using it for a specific health goal.

The bottom line

Biogénique Chromium Picolinate provides 500 mcg of chromium per capsule, with a licensed role in supporting healthy glucose metabolism and the metabolism of carbohydrates and fats. That is a narrower and more defensible message than promises about treating diabetes, suppressing appetite or producing meaningful weight loss.

For someone taking insulin, diabetes medicines or levothyroxine—or living with kidney or liver disease—the most important step is a medication and health-history check before use. For everyone else, the evidence supports realistic expectations: one mineral can participate in metabolism without becoming a shortcut around diagnosis, monitoring or the daily habits that shape cardiometabolic health.

Related resources

• Biogénique Chromium Picolinate — Current count, availability and product details.

• Quality Control — Biogénique’s quality approach and certificate information.

• Research & Innovation — How Biogénique approaches evidence and formulation.

• VitaQuiz / Find My Formula — Explore products by broader wellness goals.

References

1. Health Canada. Product label: Biogénique Chromium Picolinate, NPN 80079694. Internal controlled file reviewed 26 August 2026.

2. Health Canada. Multi-Vitamin/Mineral Supplements Monograph. Accessed 26 August 2026. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl&lang=eng

3. Health Canada. Natural Health Products Ingredients Database: Chromium (III) picolinate. Accessed 26 August 2026. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq?id=2757

4. Health Canada. Licensed Natural Health Products Database: NPN 80079694. https://health-products.canada.ca/lnhpd-bdpsnh/info?licence=80079694

5. National Institutes of Health, Office of Dietary Supplements. Chromium: Fact Sheet for Health Professionals. Accessed 26 August 2026. https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/

6. Ali A, Ma Y, Reynolds J, et al. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus. Endocr Pract. 2011;17(1):16–25. doi:10.4158/EP10131.OR. https://pubmed.ncbi.nlm.nih.gov/20634174/

7. Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46(11):1786–1791. doi:10.2337/diab.46.11.1786. https://pubmed.ncbi.nlm.nih.gov/9356027/

8. Biogénique. Chromium Picolinate product page. Reviewed 26 August 2026. https://www.biogenique.com/products/chromium-picolinate

9. Biogénique. Certificate of Analysis: Chromium, lot 240617. Approved 25 October 2024; expiry May 2026. Internal controlled file reviewed 26 August 2026.

Disclaimer